BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35078318)

  • 21. Dynamic interfacial properties of human tear-lipid films and their interactions with model-tear proteins in vitro.
    Svitova TF; Lin MC
    Adv Colloid Interface Sci; 2016 Jul; 233():4-24. PubMed ID: 26830077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic surface activity of films of lung surfactant phospholipids, hydrophobic proteins, and neutral lipids.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1995 Jun; 36(6):1283-93. PubMed ID: 7666006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films.
    Nag K; Fritzen-Garcia M; Devraj R; Panda AK
    Langmuir; 2007 Apr; 23(8):4421-31. PubMed ID: 17341098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic surface properties of pulmonary surfactant proteins SP-B and SP-C and their mixtures with dipalmitoylphosphatidylcholine.
    Taneva SG; Keough KM
    Biochemistry; 1994 Dec; 33(49):14660-70. PubMed ID: 7993894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.
    Lopez-Rodriguez E; Pascual A; Arroyo R; Floros J; Perez-Gil J
    Biophys J; 2016 Aug; 111(3):524-536. PubMed ID: 27508436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films.
    Nag K; Taneva SG; Perez-Gil J; Cruz A; Keough KM
    Biophys J; 1997 Jun; 72(6):2638-50. PubMed ID: 9168039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of levofloxacin with lung surfactant at the air-water interface.
    Ortiz-Collazos S; Estrada-López ED; Pedreira AA; Picciani PHS; Oliveira ON; Pimentel AS
    Colloids Surf B Biointerfaces; 2017 Oct; 158():689-696. PubMed ID: 28778052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamical and rheological properties of fluorinated surfactant films adsorbed at the pressurized CO2-H2O interface.
    Tewes F; Krafft MP; Boury F
    Langmuir; 2011 Jul; 27(13):8144-52. PubMed ID: 21630699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the compression ratio on properties of lung surfactant (bovine lipid extract surfactant) films.
    Lu JY; Distefano J; Philips K; Chen P; Neumann AW
    Respir Physiol; 1999 Jan; 115(1):55-71. PubMed ID: 10344415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hydrophobic alkylated gold nanoparticles on the phase behavior of monolayers of DPPC and clinical lung surfactant.
    Tatur S; Badia A
    Langmuir; 2012 Jan; 28(1):628-39. PubMed ID: 22118426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular insights on the interference of simplified lung surfactant models by gold nanoparticle pollutants.
    Hossain SI; Gandhi NS; Hughes ZE; Gu YT; Saha SC
    Biochim Biophys Acta Biomembr; 2019 Aug; 1861(8):1458-1467. PubMed ID: 31194957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Langmuir monolayer of artificial pulmonary surfactant mixtures with an amphiphilic peptide at the air/water interface: comparison of new preparations with surfacten (Surfactant TA).
    Nakahara H; Lee S; Sugihara G; Chang CH; Shibata O
    Langmuir; 2008 Apr; 24(7):3370-9. PubMed ID: 18315015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical surface potential of pulmonary surfactant.
    Leonenko Z; Rodenstein M; Döhner J; Eng LM; Amrein M
    Langmuir; 2006 Nov; 22(24):10135-9. PubMed ID: 17107011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity.
    Suri LN; McCaig L; Picardi MV; Ospina OL; Veldhuizen RA; Staples JF; Possmayer F; Yao LJ; Perez-Gil J; Orgeig S
    Biochim Biophys Acta; 2012 Jul; 1818(7):1581-9. PubMed ID: 22387458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of serum with lung surfactant extract in the bronchiolar and alveolar airway models.
    Nag K; Hillier A; Parsons K; Garcia MF
    Respir Physiol Neurobiol; 2007 Aug; 157(2-3):411-24. PubMed ID: 17350899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the low surface tension of lung surfactant.
    Zhang H; Wang YE; Fan Q; Zuo YY
    Langmuir; 2011 Jul; 27(13):8351-8. PubMed ID: 21650180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.
    Taneva S; Keough KM
    Biophys J; 1994 Apr; 66(4):1137-48. PubMed ID: 8038385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptations to hibernation in lung surfactant composition of 13-lined ground squirrels influence surfactant lipid phase segregation properties.
    Suri LN; Cruz A; Veldhuizen RA; Staples JF; Possmayer F; Orgeig S; Perez-Gil J
    Biochim Biophys Acta; 2013 Aug; 1828(8):1707-14. PubMed ID: 23506681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Interfacially Driven Vehiculization of Corticosteroids by Pulmonary Surfactant.
    Hidalgo A; Salomone F; Fresno N; Orellana G; Cruz A; Perez-Gil J
    Langmuir; 2017 Aug; 33(32):7929-7939. PubMed ID: 28738158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling Lung Surfactant Interactions with Benzo[a]pyrene.
    Stachowicz-Kuśnierz A; Trojan S; Cwiklik L; Korchowiec B; Korchowiec J
    Chemistry; 2017 Apr; 23(22):5307-5316. PubMed ID: 28230285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.